Administration of CD.JEVAX: Primary immunization for persons at least 9 months of age and older, a single dose of 0.5 ml subcutaneously, and a booster dose can be given from 3 months to 1 year after primary dose.
How to administer CD.JEVAX: After reconstitution with the diluent (sterile water for injection), the vaccine should be used within 1 hour.
The deltoid muscle of right or left arm is the recommended site of injection. The skin at the site of injection first should be disinfected with alcohol or iodine tincture and allowed to dry thoroughly before injection.
The vaccine should not be injected into a blood vessel.
Vaccine recipients should be monitored during and after receiving CD.JEVAX and if any reactions (fever, convulsion etc.) are observed, a healthcare provider should be contacted.
As for any vaccine, adequate treatment provision, including epinephrine, should be available for immediate use in case an anaphylactic reaction occur.